Author:
Fischer Katharina Elisabeth,Leidl Reiner
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference64 articles.
1. Montori, V.M., Guyatt, G.H.: Progress in evidence-based medicine. JAMA 300(15), 1814–1816 (2008). doi: 10.1001/jama.300.15.1814
2. Stafinski, T., Menon, D., Philippon, D.J., McCabe, C.J.: Health technology funding decision-making processes around the world: the same, yet different. Pharmacoeconomics 29(6), 475–495 (2011). doi: 10.2165/11586420-000000000-00000
3. Hutton, J., McGrath, C., Frybourg, J.M., Tremblay, M., Bramley-Harker, E., Henshall, C.: Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int. J. Technol. Assess. Health Care 22(1), 10–18 (2006). doi: 10.1017/S0266462306050781
4. Anell, A.: Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. Eur. J. Health Econ. 5(1), 28–35 (2004). doi: 10.1007/s10198-003-0195-0
5. Velasco-Garrido, M., Zentner, A., Busse, R.: Health systems, health policy and health technology assessment. In: Observatory, E. (ed.) Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential, pp. 53–78. World Health Organization, Copenhagen (2008)
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献